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Background
The ongoing scale-up of antiretroviral therapy (ART) in
low-resource settings continues to improve the prog-
nosis of HIV-infected individuals, necessitating a focus
on long-term case management especially in women.
Facing the particularly high burden of cervical cancer in
sub-Saharan Africa, preventive measures are therefore
becoming an integral component of a comprehensive
approach to the management of patients. We describe
here some of the operational aspects of a cervical cancer
screening procedure based on visual inspection among
HIV-positive women attending ART clinics in Abidjan.
Methods
A cross-sectional study is being conducted in two HIV
clinics of Abidjan, since August 2009. A mobile team
composed of three trained midwives and a senior gyne-
cologist is in charge of proposing cervical screening
based on visual inspection to all HIV-infected women
attending participating clinics. Midwives are in charge
to perform visual inspection of the cervix with acetic
acid (IVA) and lugol’s iodine (IVL). Exclusion criteria
are following: no previous cervical cancer or total hys-
terectomy, aged <25 or >59 years, pregnancy over
20 weeks. They refer positively screened women (IVA+
or IVL+), to a gynecologist in charge of the colposcopy
examination (and biopsy if needed). Women with con-
firmed lesions are proposed an adapted treatment
according to local available resources.
Results
Of the first 1,653 HIV-positive women, who attended
the cervical screening consultations, 49 were not eligible
and 103 were not assessable because of a prevalent cer-
vical infection. The median age of the 1,501 screened
women was 37 (IQR 32-43) years, and 1171 (78%) were
on ART. 133 (9%) women were positively screened for
cervical pre malignancy and referred for medical exami-
nation. 69 (4.6%, 95% CI 3.5-5.6) were confirmed by col-
posocopy and had histological investigation. Results of
the 69 biopsy performed were as follows; 48 cervical
intraepithelial neoplasia (CIN) of grade 1, 8 CIN grade 2
or 3, 2 invasive carcinoma and 10 nonmalignant find-
ings. 22 patients were treated with cryotherapy, 16 were
referred for surgical excision, and 31 were proposed a
gynecological followup.
Conclusion
Several barriers were identified as limiting the ability of
visual inspection used as a cervical screening method
such as a high rate of cervical infection or a high rate of
false-positive cervical lesions. Health care systems in
West African countries cannot afford the financial and
structural burdens of a conventional cervical screening
program. Strategies adapted to HIV-infected women and
relying on visual inspection appear feasible despite
stated limitations and should be further evaluated.
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